MedTrace Logo

Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer

NCT01463007 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-05-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the rate of early and intermediate toxicity related to the AccuBoost System for delivery of APBI in women with resected, early stage breast cancer.

Conditions

Interventions

RADIATION

Accelerated partial breast irradiation

Accuboost APBI 34.0 Gy in 10 fractions

OTHER

Extended Follow up

This arm extends follow up at the Rhode Island Hospital location to 5 years. Annual mammograms and additional documentation is required to be submitted only if completed.

Sponsors & Collaborators

  • The Miriam Hospital

    collaborator OTHER

  • Rhode Island Hospital

    collaborator OTHER

  • Jaroslaw Hepel

    lead OTHER

Principal Investigators

  • Jaroslaw Hepel, MD · Brown University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-09-12
Completion
2021-04-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01463007 on ClinicalTrials.gov